Two assistant professors at the Medical School may have discovered a substance that reduces tissue damage after heart attacks in humans.
Dr. Peter R. Maroko and Dr. Charles B. Carpenter, assistant professors of Medicine and researchers at the Peter Bent Brigham Hospital, found that Cobra Venom Factor (CVF) increases cell resistance that results in reduced death of coronary tissue when administered to dogs after heart attacks.
The discovery is the result of the first part of a two-year study funded by the hospital.
In the second part of the study, Maroko and Carpenter will test the safety of CVF and determine its effect on humans.
"If CVF is proved to have the same effect on humans that it has on dogs, then we will have made a big step forward in the treatment of heart disease," Maroko said yesterday.
Heart attacks are caused by the formation of an obstacle that reduces blood flow in a coronary artery. CVF increases the resistance of cells that would die because of the lessened blood flow, thereby decreasing tissue death.
"CVF would minimize the damage caused by a heart attack," Maroko said.
Read more in News
the stageRecommended Articles
-
Cheney's Heart Condition Could Pose Serious RiskVice President Richard B. Cheney's heart condition may adversely affect his job performance, said professors from the Harvard Medical School
-
Retirement, Coronaries LinkedWorking men suffer 80 per cent fewer heart attacks than retired men of the same age, a team of Harvard
-
Aspirin Study to Examine Women's Heart Attack RiskRecent studies on the effects of regular doses of aspirin on men have found a significant reduction in the risk
-
Playing Plumber With Our ArteriesWASHINGTON, D.C.--On the surface, it's just a simple plumbing problem. One of your pipes is clogged, and it needs to
-
Weight-Training Healthy for HeartA study by Harvard researchers has clarified the relationship between different types of exercise and the decreased risk of coronary
-
Stem Cell Research Holds Promise for Heart Disease Damaged Heart TissueIn a significant finding that may ultimately prolong the life of heart attack victims, a team of researchers at the
